Products

NoPass.me

Accountless MFA Authentication API

nopass.me SourceSoftware Development / Auth, Payments & Billing Infrastructure

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Sep 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
Charlie Laurent
No social account linked
Launched
5y ago
2021-04-06 · Est.

Traffic

Monthly visitsData through Sep 2026 · Oct 2026 pending

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Open-source identity verification

    Apr 6, 2021 · 5y agoLaunch page

Open Source & Self-Hosting

GitHub · MCP / Skill
GitHub Stars
Public repo
Forks
1
License
See repository
Primary language
—

Traffic sources

Sep 2026

Traffic breakdown

Channels

  • Organic Search40%
  • Direct25%
  • Referrals14%
  • Display Ads7%
  • Other15%

Countries

  • Japan100%

Search

Domain authority —Domain registered 2021-03-07

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2021-04-06

Key pages

Weekly snapshots

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does NoPass.me get?
Vaneform estimates <5K website visits in 2026-09. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is NoPass.me and what platforms does it support?
NoPass.me is catalogued under Auth, Payments & Billing Infrastructure: Accountless MFA Authentication API. Supported platforms: API.
Is NoPass.me open source?
NoPass.me has a public repository (https://github.com/Clevyio/nopass.me) with its source repository published.Source

Related products in this category

Software Development / Auth, Payments & Billing Infrastructure

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.